Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT

Can-Fite BioPharma (CANF) Current Leases (2016 - 2020)

Updated

Can-Fite BioPharma (CANF) reported Current Leases of $43,000 for Q4 2020, up 19.4% from $36,000 a year earlier.

Analysis

Can-Fite BioPharma (CANF) Current Leases (2016 - 2020) Analysis & Trends

Dating back to Q4 2016, Can-Fite BioPharma's Current Leases record includes 4 quarters.

  • Current Leases has a four-year compound annual growth rate of -74.1% (FY2016 to FY2020).
  • By year, Current Leases came in at $36,000 in FY2019, $6.25 million in FY2017 (-35.1%) and $9.63 million in FY2016.
  • The Q4 2020 figure ranks as the highest quarterly Current Leases since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -2.32 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 43,000.00
Dec 31, 2019 36,000.00
Dec 31, 2017 6.25 Mn
Dec 31, 2016 9.63 Mn
API Access

Can-Fite BioPharma Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CANF&period=max&api_key=YOUR_API_KEY